Cystic Fibrosis News Today Daily Digest

Cystic Fibrosis Weekly Update Contents: Azithromycin Slows Lung Function Decline in CF Patients with P. aeruginosa, Study Says Azithromycin Slows Lung Function Decline in CF Patients with P. aeruginosa, Study Says Mar 23, 2020 07:00 am | David Melamed, PhD Prolonged use of the antibiotic azithromycin resulted in a 37% slower rate of lung function decline in cystic fibrosis (CF) patients with persistent Pseudomonas aeruginosa infection over a three-year period, a study found. The study, “Pulmonary Outcomes Associated with Long-Term Azithromycin Therapy in Cystic Fibrosis,” was published in the American Journal of Respiratory and Critical […] The post Azithromycin Slows Lung Function Decline in CF Patients with P. aeruginosa, Study Says appeared first on Cystic Fibrosis News Today. Read More   Recent News Global Rare Disease Group’s Focus: 1,000 New Therapies by 2027, Despite COVID-19 Armata Receives Up to $5M From CF Foundation to Develop Phage Therapy AP-PA02 Hanging by a Hope During the Coronavirus Crisis Student Project Aims to Make CF Physiotherapy a Game West Virginia University Grad Student Assessing CF Teens’ Nutrition